SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Nikola Tesla — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientNikola Tesla
Date of birth1856-07-10
IdentifiersMRN HR-NI009-SYN-TD; SSN (made up) 000-09-7408
Document date1902-01-27
AuthorBranimir Kovač-Holt, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Two-week sertraline tolerability and safety check; psychiatry consultation today. [S]

History of Present Illness

Mr. Tesla returns two weeks after starting sertraline 50 mg each morning. He had mild nausea for four days and looser stools, now settled, and no headache, restlessness, or change in sleep. He has missed no doses. He has had his first session of exposure and response prevention and began building his list of feared situations. He still washes his hands about 50 times a day, but uses the ointment after each wash and the cracks are less painful. He has eaten two meals a day most days. He has had no suicidal thoughts. He saw Dr. Feinberg-Osei of psychiatry this morning. [S]

ElementDetail
Medication toleranceMild nausea and loose stools for four days, now settled
AdherenceNo missed doses
RitualsWashing about 50 times a day; counting and calculating unchanged
PsychotherapyFirst ERP session; hierarchy started
SafetyNo suicidal thoughts
Y-BOCS27, down from 28

Review of Systems

SystemResultFinding
GastrointestinalNegativeEarly nausea settled; eating two meals most days
IntegumentaryPositiveHand cracks less painful
NeurologicalNegativeNo headache or tremor
PsychiatricPositiveObsessions and rituals unchanged; no suicidal thoughts, elevated mood, or racing thoughts

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Sertraline 50 mg oral tablet, one tablet by mouth each morningOne tablet by mouth each morningOral route1902-01-13 to 1902-02-24completedS
White petrolatum ointment, apply to both hands after each wash and at bedtimeApply a thin layer to both hands after washing and at bedtimeTopical route1902-01-13activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1902-01-27Body height188cmS
1902-01-27Body weight63.9kgS
1902-01-27Body mass index (BMI) [Ratio]18.1kg/m2S
1902-01-27Systolic blood pressure114mm[Hg]S
1902-01-27Diastolic blood pressure70mm[Hg]S
1902-01-27Heart rate72/minS
1902-01-27Respiratory rate14/minS
1902-01-27Body temperature36.6CelS
1902-01-27Oxygen saturation in Arterial blood by Pulse oximetry99%S

Physical Exam

Vital signs recorded on 1902-01-27; see the Vital Signs section. [S]

SystemFinding
GeneralTall, thin, immaculately dressed; washed his hands on arrival, which was offered
SkinExamined without touch at his request: dry, red skin over the backs of both hands with fewer and shallower fissures than two weeks ago
Mental statusFormal and precise; mood "the same, but hopeful"; affect anxious; obsessions with good insight; no hallucinations or delusions; no suicidal ideation

Problems

ProblemClinical statusVerificationCodeProvenance
Obsessive-compulsive disorder, severe (Y-BOCS 28), with good insight: contamination, symmetry, and number obsessions; washing, counting, repeating in threes, and calculating compulsions; synthetic modern diagnosis linked to his own accounts of counting and calculating rituals and aversionsactiveconfirmed F42.2S — Synthetic modern diagnosis. His rituals and aversions are documented in his own words (D); calling them obsessive-compulsive disorder is a retrospective interpretation (R), and no diagnosis was made in his lifetime.
Irritant contact dermatitis of both hands from washing them 40 to 60 times a dayactiveconfirmed L24.9S — Synthetic consequence of washing compulsions.
Underweight (BMI 18.1) with about 4 kg weight loss over six months, from skipped meals and food-calculating ritualsactiveconfirmed R63.6S — Synthetic nutritional consequence echoing his documented habit of calculating the volume of food before eating.
Insufficient sleep, four hours a night, from late work and night-time ritualsactiveconfirmed Z72.820S — Synthetic sleep problem echoing his documented claims about very short sleep.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyY-BOCS severity score (recorded in the note; no LOINC code found)At baseline and about every 4 to 6 weeks during acute treatmentCompleted today27, down from 28 at intake
SurveyComorbidity review: tics, bipolar disorder, psychosis, hoarding, body dysmorphic symptoms, and personalityAt the initial assessmentCompleted todayPsychiatric interview today found none of these; depressive and anxiety symptoms are secondary to the OCD
SurveySuicide risk reassessment (C-SSRS Since Last Visit and PHQ-9 item 9 when given)Every visit during acute treatmentCompleted todayNo suicidal thoughts, intent, plan, or behavior since intake. Protective factors unchanged. Safety plan reviewed
Medication safetySertraline adherence and adverse effects (nausea, diarrhea, sleep, activation, sexual effects)Every visit and two weeks after each dose increaseCompleted todayEarly nausea and loose stools settled; no activation; no missed doses; dose unchanged at 50 mg
Self-managementExposure and response prevention attendance and homeworkEvery visit during acute treatmentCompleted todayFirst session done; hierarchy started
ExaminationWeight and BMIEvery visit while underweightCompleted today63.9 kg, BMI 18.1, steady
ExaminationHand skinEvery visit while dermatitis is presentCompleted todayFewer and shallower fissures
ReferralPsychiatry consultationFor severe OCD at the start of treatmentCompleted todaySeen today; diagnosis confirmed; titration plan agreed
Medication safetyAntipsychotic augmentation monitoring (weight, glucose, lipids, movement)Only if an antipsychotic is addedNot indicatedNo augmentation; responding to sertraline and ERP

Goal progress:

Guideline basis: Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2007); Guideline Watch: Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2013); Obsessive-compulsive disorder and body dysmorphic disorder: treatment (CG31) (2005); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024)

Follow-up: Review in four weeks, six weeks after starting sertraline. Next scheduled visit 1902-02-24: six-week OCD treatment review. [S]